Literature DB >> 25125627

Significant histologic features differentiating cellular fibroadenoma from phyllodes tumor on core needle biopsy specimens.

Saba Yasir1, Roberto Gamez2, Sarah Jenkins3, Daniel W Visscher1, Aziza Nassar4.   

Abstract

OBJECTIVES: Cellular fibroepithelial lesions (CFELs) are a heterogeneous group of tumors encompassing cellular fibroadenoma (CFA) and phyllodes tumor (PT). Distinction between the two is challenging on core needle biopsy (CNB) specimens. The objective of this study was to evaluate histologic features that can help distinguish PT from CFA on CNB specimens.
METHODS: Records of all patients diagnosed with CFELs on CNB specimens with follow-up excision between January 2002 and December 2012 were retrieved. Histopathologic stromal features were evaluated on CNB specimens, including mitoses per 10 high-power fields (hpf), overgrowth, increased cellularity, fragmentation, adipose tissue infiltration, heterogeneity, subepithelial condensation, and nuclear pleomorphism.
RESULTS: Twenty-seven (42.2%) of 64 were diagnosed as PT (24 benign PTs and three borderline PTs) and 37 (57.8%) as CFA on excision. All features except for increased stromal cellularity were statistically significant. The average number of histologic features seen in PT and CFA was 3.9 and 1.4, respectively (odds ratio [OR], 7.27; 95% confidence interval [CI], 2.44-21.69; P = .0004). The average number of mitoses per 10 hpf was 3.0 for PT compared with 0.8 for CFA (OR, 2.14; 95% CI, 1.18-3.86; P = .01).
CONCLUSIONS: The presence of mitoses (three or more) and/or total histologic features of three or more on CNB specimens were the most helpful features in predicting PT on excision. Copyright© by the American Society for Clinical Pathology.

Entities:  

Keywords:  Biopsy specimens; Fibroadenoma; Fibroepithelial lesions; Needle cores; Phyllodes tumor

Mesh:

Year:  2014        PMID: 25125627      PMCID: PMC4361036          DOI: 10.1309/AJCPZUZ96RESGPUP

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  24 in total

1.  Analysis of histological features in needle core biopsy of breast useful in preoperative distinction between fibroadenoma and phyllodes tumour.

Authors:  J Mike Morgan; Anthony G Douglas-Jones; Sanjeev K Gupta
Journal:  Histopathology       Date:  2010-03       Impact factor: 5.087

Review 2.  Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors.

Authors:  R J Barth
Journal:  Breast Cancer Res Treat       Date:  1999-10       Impact factor: 4.872

3.  Phyllodes tumours of the breast - differentiating features in core needle biopsy.

Authors:  Alex K H Tsang; Siu Ki Chan; Christopher C F Lam; Philip C W Lui; Helen H L Chau; Puay Hoon Tan; Gary M Tse
Journal:  Histopathology       Date:  2011-09-14       Impact factor: 5.087

4.  Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast.

Authors:  C G Kleer; T J Giordano; T Braun; H A Oberman
Journal:  Mod Pathol       Date:  2001-03       Impact factor: 7.842

5.  The sensitivity of needle core biopsy in combination with other investigations for the diagnosis of phyllodes tumours of the breast.

Authors:  S T Ward; A J Jewkes; B G Jones; S Chaudhri; R K Hejmadi; T Ismail; M T Hallissey
Journal:  Int J Surg       Date:  2012-08-11       Impact factor: 6.071

6.  Factors associated with phyllodes tumor of the breast after core needle biopsy identifies fibroepithelial neoplasm.

Authors:  Daniel J Gould; Jessica A Salmans; Brian K Lassinger; Alejandro Contreras; Carolina Gutierrez; Elizabeth Bonefas; Kathleen R Liscum; Eric J Silberfein
Journal:  J Surg Res       Date:  2012-04-14       Impact factor: 2.192

7.  Predictors of phyllodes tumours on core biopsy specimens of fibroepithelial neoplasms.

Authors:  Ana Richelia Jara-Lazaro; Meenakshi Akhilesh; Aye Aye Thike; Philip Chi-Wai Lui; Gary Man-Kit Tse; Puay Hoon Tan
Journal:  Histopathology       Date:  2010-08       Impact factor: 5.087

8.  Histological features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast.

Authors:  A H S Lee; Z Hodi; I O Ellis; C W Elston
Journal:  Histopathology       Date:  2007-09       Impact factor: 5.087

9.  "Missed" diagnoses of phyllodes tumor on breast biopsy: pathologic clues to its recognition.

Authors:  Sophia Yohe; I-Tien Yeh
Journal:  Int J Surg Pathol       Date:  2008-04       Impact factor: 1.271

Review 10.  Nonmalignant lesions in breast core needle biopsies: to excise or not to excise?

Authors:  Timothy W Jacobs; James L Connolly; Stuart J Schnitt
Journal:  Am J Surg Pathol       Date:  2002-09       Impact factor: 6.394

View more
  13 in total

Review 1.  Fibroepithelial tumours of the breast-a review.

Authors:  Melinda F Lerwill; Andrew H S Lee; Puay Hoon Tan
Journal:  Virchows Arch       Date:  2021-09-10       Impact factor: 4.064

Review 2.  Fibroepithelial lesions revisited: implications for diagnosis and management.

Authors:  Puay Hoon Tan
Journal:  Mod Pathol       Date:  2020-05-27       Impact factor: 7.842

3.  Fibroepithelial Lesions (FELs) of the Breast: Is Routine Excision Always Necessary?

Authors:  Jessica Limberg; Kelly Barker; Syed Hoda; Rache Simmons; Aya Michaels; Jennifer L Marti
Journal:  World J Surg       Date:  2020-05       Impact factor: 3.352

Review 4.  Phyllodes tumours of the breast: a consensus review.

Authors:  Benjamin Y Tan; Geza Acs; Sophia K Apple; Sunil Badve; Ira J Bleiweiss; Edi Brogi; José P Calvo; David J Dabbs; Ian O Ellis; Vincenzo Eusebi; Gelareh Farshid; Stephen B Fox; Shu Ichihara; Sunil R Lakhani; Emad A Rakha; Jorge S Reis-Filho; Andrea L Richardson; Aysegul Sahin; Fernando C Schmitt; Stuart J Schnitt; Kalliopi P Siziopikou; Fernando A Soares; Gary M Tse; Anne Vincent-Salomon; Puay Hoon Tan
Journal:  Histopathology       Date:  2016-01       Impact factor: 5.087

5.  A five-gene reverse transcription-PCR assay for pre-operative classification of breast fibroepithelial lesions.

Authors:  Wai Jin Tan; Igor Cima; Yukti Choudhury; Xiaona Wei; Jeffrey Chun Tatt Lim; Aye Aye Thike; Min-Han Tan; Puay Hoon Tan
Journal:  Breast Cancer Res       Date:  2016-03-09       Impact factor: 6.466

6.  TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast.

Authors:  Masayuki Yoshida; Reiko Ogawa; Hiroshi Yoshida; Akiko Maeshima; Yae Kanai; Takayuki Kinoshita; Nobuyoshi Hiraoka; Shigeki Sekine
Journal:  Br J Cancer       Date:  2015-09-10       Impact factor: 7.640

7.  Fibroadenoma versus phyllodes tumor: a vexing problem revisited!

Authors:  Santosh Tummidi; Kanchan Kothari; Mona Agnihotri; Leena Naik; Prashant Sood
Journal:  BMC Cancer       Date:  2020-07-13       Impact factor: 4.430

8.  Value of Conventional MRI Texture Analysis in the Differential Diagnosis of Phyllodes Tumors and Fibroadenomas of the Breast.

Authors:  Nianping Jiang; Li Zhong; Chunlai Zhang; Xiangguo Luo; Peng Zhong; Xiaoguang Li
Journal:  Breast Care (Basel)       Date:  2020-06-23       Impact factor: 2.860

9.  Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing.

Authors:  Cedric Chuan Young Ng; Nur Diyana Md Nasir; Benjamin Nathanael Loke; Timothy Kwang Yong Tay; Aye Aye Thike; Vikneswari Rajasegaran; Wei Liu; Jing Yi Lee; Peiyong Guan; Abner Herbert Lim; Kenneth Tou En Chang; Mihir Ananta Gudi; Preetha Madhukumar; Benita Kiat Tee Tan; Veronique Kiak Mien Tan; Chow Yin Wong; Wei Sean Yong; Gay Hui Ho; Kong Wee Ong; George Wai Cheong Yip; Boon Huat Bay; Patrick Tan; Bin Tean Teh; Puay Hoon Tan
Journal:  Mod Pathol       Date:  2021-03-16       Impact factor: 7.842

10.  Localization and hypersecretion of nerve growth factor in breast phyllodes tumors: Evidence from a preliminary study.

Authors:  Ashutosh Kumar; Khursheed Raza; Tapas C Nag; Anurag Srivastava; Ritu Sehgal
Journal:  Cancer Rep (Hoboken)       Date:  2020-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.